Cancer Research  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 47, 4552-4559, September 1, 1987]
© 1987 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Halper, J.
Right arrow Articles by Moses, H. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Halper, J.
Right arrow Articles by Moses, H. L.

Purification and Characterization of a Novel Transforming Growth Factor1

Jaroslava Halper2 and Harold L. Moses3

Departments of Pathology [J. H., H. L. M.] and Cell Biology [H. L. M.], Mayo Clinic/Foundation, Rochester, Minnesota 55905

Previous studies have indicated that an autostimulatory transforming growth factor was required for the optimal growth of SW-13 adrenal carcinoma cells in soft agar. The production of SW-13 colony-stimulating activity by other human malignant cell lines of both epithelial and mesenchymal origin has been demonstrated. Evidence was presented indicating that the stimulating activity detected in crude acid-ethanol extracts was an acid- and heat-stable polypeptide requiring disulfide bonds for full activity. This activity was detected more frequently in tumors and human cancer cells in culture of epithelial origin than of mesenchymal origin and in a variety of nonneoplastic tissues. In the present study, this activity, termed epithelial transforming growth factor (TGFe) because of its ability to stimulate soft agar growth of certain epithelial cells, was partially purified from bovine kidney. Fourfold purification of the kidney acid-ethanol extract with 50% maximal growth-stimulatory activity of 10 µg was achieved using molecular sieve chromatography where TGFe eluted with an apparent molecular weight of 20,000–25,000. The next purification step, molecular sieve high performance liquid chromatography, yielded a 50% maximal growth-stimulatory activity of 50 ng and an 800-fold purification from the initial acid-ethanol extract. TGFe eluted in the Mr 11,000 range. Reversed phase high performance liquid chromatography with a C18 column was then used, yielding a single or double peak of SW-13 colony-stimulating activity at 30–35% acetonitrile. The degree of purification was 11,000-fold with a 50% maximal growth-stimulatory activity of 3.5 ng. Analysis of the peak on 12.5% sodium dodecyl sulfate-polyacrylamide gel electrophoresis revealed a major and sometimes single band with a molecular weight of 23,000–25,000. Extraction of protein from the polyacrylamide gel demonstrated that only the Mr 23,000–25,000 band stimulated soft agar growth of SW-13 cells. The biological activity of the partially purified TGFe was found to differ from other known growth factors with regard to its ability to stimulate soft agar growth of SW-13 cells with the exception of basic fibroblast growth factor (FGF). The acid lability of FGF, the different molecular weights of these two growth factors, the lack of stimulation of soft agar growth of A431 cells, and the lack of binding of TGFe to FGF receptors indicated that TGFe was not related to basic FGF. Partially purified TGFe was also found to stimulate soft agar growth of two squamous cell carcinoma lines, A431 and D562, and the mouse embryo-derived AKR-2B cells. These data suggest that TGFe is a unique factor distinct from those previously described and it is speculated that TGFe may play a role in normal and neoplastic growth of epithelial cells.

1 This investigation was supported by USPHS Grant CA 27217 awarded by the National Cancer Institute, Department of Health and Human Services.

2 To whom requests for reprints should be addressed. Present address: Department of Pathology, College of Veterinary Medicine, University of Georgia, Athens, GA 30602.

3 Present address: Department of Cell Biology, Vanderbilt University School of Medicine, Nashville, TN 37232.

Received 12/16/86. Revised 5/22/87. Accepted 6/ 5/87.




This article has been cited by other articles:


Home page
Cancer Res.Home page
Z. He, A. Ismail, L. Kriazhev, G. Sadvakassova, and A. Bateman
Progranulin (PC-Cell-derived Growth Factor/Acrogranin) Regulates Invasion and Cell Survival
Cancer Res., October 1, 2002; 62(19): 5590 - 5596.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
R. Daniel, Z. He, K. P. Carmichael, J. Halper, and A. Bateman
Cellular Localization of Gene Expression for Progranulin
J. Histochem. Cytochem., July 1, 2000; 48(7): 999 - 1010.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
Z. He and A. Bateman
Progranulin Gene Expression Regulates Epithelial Cell Growth and Promotes Tumor Growth in Vivo
Cancer Res., July 1, 1999; 59(13): 3222 - 3229.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1987 by the American Association for Cancer Research.